Institute of Human Genetics, Newcastle University, Newcastle-upon-Tyne, UK.
J Pathol. 2010 Nov;222(3):223-6. doi: 10.1002/path.2753.
The RNA binding protein Sam68 (Src-associated in mitosis 68 kD) is implicated in cell signalling, transcriptional regulation, pre-mRNA splicing, and is overexpressed and/or hyperphosphorylated in breast, prostate, and renal cancers. Sam68 has roles in normal breast development; however, a study by Song et al published in this issue of The Journal of Pathology reports overexpression of nuclear and cytoplasmic Sam68 protein in a large cohort of clinical breast tumours, implicating Sam68 as a potential prognostic indicator and target for therapy. In breast cancer cells, nuclear Sam68 protein might affect the expression of cancer-relevant genes and/or modulate exon splicing patterns in a dose-dependent manner. Sam68-regulated expression of alternative transcripts may help drive mammary tumourigenesis. The high levels of cytoplasmic Sam68 protein observed in breast cancer cells could also impact on cellular signalling pathways important for mammary tumour cell biology.
RNA 结合蛋白 Sam68(有丝分裂相关 68kD Src 相关蛋白)参与细胞信号转导、转录调控、前体 mRNA 剪接,在乳腺癌、前列腺癌和肾癌中过度表达和/或过度磷酸化。Sam68 在正常乳腺发育中具有作用;然而,Song 等人在本期《病理学杂志》上发表的一项研究报告称,在大量临床乳腺肿瘤中核内和细胞质 Sam68 蛋白表达过度,提示 Sam68 可能是一种潜在的预后指标和治疗靶点。在乳腺癌细胞中,核内 Sam68 蛋白可能以剂量依赖的方式影响癌症相关基因的表达和/或调节外显子剪接模式。Sam68 调节的替代转录本表达可能有助于推动乳腺肿瘤发生。在乳腺癌细胞中观察到的高水平细胞质 Sam68 蛋白也可能影响对乳腺肿瘤细胞生物学很重要的细胞信号通路。